Elastic Fiber Fragmentation Increases Transmural Hydraulic Conductance and Solute Transport in Mouse Arteries.
elastic fiber matrix
fibulin-5
porous membrane
Journal
Journal of biomechanical engineering
ISSN: 1528-8951
Titre abrégé: J Biomech Eng
Pays: United States
ID NLM: 7909584
Informations de publication
Date de publication:
01 Feb 2019
01 Feb 2019
Historique:
received:
03
08
2018
pubmed:
6
12
2018
medline:
6
12
2018
entrez:
6
12
2018
Statut:
ppublish
Résumé
Transmural advective transport of solute and fluid was investigated in mouse carotid arteries with either a genetic knockout of fibulin-5 (Fbln5-/-) or treatment with elastase to determine the influence of a disrupted elastic fiber matrix on wall transport properties. Fibulin-5 is an important director of elastic fiber assembly. Arteries from Fbln5-/- mice have a loose, noncontinuous elastic fiber network and were hypothesized to have reduced resistance to advective transport. Experiments were carried out ex vivo at physiological pressure and axial stretch. Hydraulic conductance (LP) was measured to be 4.99 × 10-6±8.94 × 10-7, 3.18-5±1.13 × 10-5 (p < 0.01), and 3.57 × 10-5 ±1.77 × 10-5 (p < 0.01) mm·s-1·mmHg-1 for wild-type, Fbln5-/-, and elastase-treated carotids, respectively. Solute fluxes of 4, 70, and 150 kDa fluorescein isothiocyanate (FITC)-dextran were statistically increased in Fbln5-/- compared to wild-type by a factor of 4, 22, and 3, respectively. Similarly, elastase-treated carotids demonstrated a 27- and 13-fold increase in net solute flux of 70 and 150 kDa FITC-dextran, respectively, compared to untreated carotids, and 4 kDa FITC-dextran was unchanged between these groups. Solute uptake of 4 and 70 kDa FITC-dextran within Fbln5-/- carotids was decreased compared to wild-type for all investigated time points. These changes in transport properties of elastic fiber compromised arteries have important implications for the kinetics of biomolecules and pharmaceuticals in arterial tissue following elastic fiber degradation due to aging or vascular disease.
Identifiants
pubmed: 30516242
pii: 2718211
doi: 10.1115/1.4042173
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAMS NIH HHS
ID : P30 AR057235
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL115560
Pays : United States
Organisme : NIH HHS
ID : S10 OD021629
Pays : United States
Organisme : NIBIB NIH HHS
ID : T32 EB018266
Pays : United States
Informations de copyright
Copyright © 2019 by ASME.